PD-1 and LAG-3 Checkpoint Blockade: Potential Avenues for Therapy in B-Cell Lymphoma

The dependence of cancer on an immunotolerant tumor microenvironment (TME) is well established. Immunotherapies that overcome tumor-induced immune suppression have been central to recent advancements in oncology. This is highlighted by the success of agents that interrupt PD-1 mediated immune suppre...

Descripción completa

Detalles Bibliográficos
Autores principales: Tobin, Joshua W. D., Bednarska, Karolina, Campbell, Ashlea, Keane, Colm
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151045/
https://www.ncbi.nlm.nih.gov/pubmed/34068762
http://dx.doi.org/10.3390/cells10051152

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151045/
https://www.ncbi.nlm.nih.gov/pubmed/34068762
http://dx.doi.org/10.3390/cells10051152

Ejemplares similares